Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial

Berge Eivind; Cohen Geoffrey; Roaldsen Melinda B.; Lundstrom Erik; Isaksson Eva; Rudberg Ann-Sofie; Slot Karsten Bruins; Forbes John; Smith Joel; Drever Jonathan; Wardlaw Joanna M.; Lindley Richard I.; Sandercock Peter A. G.; Whiteley William N.

首页> 外文期刊>Lancet Neurology >Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial

【24h】

Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial

机译：阿替普酶对缺血性中风（IST-3）后生存的影响：一项随机，对照，开放标签试验的三年随访

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background The effect of alteplase on patient survival after ischaemic stroke is the subject of debate. We report the effect of intravenous alteplase on long-term survival after ischaemic stroke of participants in the Third International Stroke Trial (IST-3).

机译：背景技术阿替普酶对缺血性中风后患者生存的影响尚有争议。我们在第三次国际中风试验（IST-3）中报告了缺血性中风后静脉阿替普酶对长期生存的影响。

著录项

来源
《Lancet Neurology 》 |2016年第10期| 共7页
作者
Berge Eivind; Cohen Geoffrey; Roaldsen Melinda B.; Lundstrom Erik; Isaksson Eva; Rudberg Ann-Sofie; Slot Karsten Bruins; Forbes John; Smith Joel; Drever Jonathan; Wardlaw Joanna M.; Lindley Richard I.; Sandercock Peter A. G.; Whiteley William N.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial [J] . Berge Eivind, Cohen Geoffrey, Roaldsen Melinda B., Lancet Neurology . 2016 ,第10期

机译：阿替普酶对缺血性中风（IST-3）后生存的影响：一项随机，对照，开放标签试验的三年随访
2. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): A randomised controlled trial [J] . SandercockP., WardlawJ.M., LindleyR.I., The Lancet . 2012 ,第9834期

机译：重组组织纤溶酶原激活剂在急性缺血性中风后6小时内进行静脉溶栓治疗的利弊（第三项国际中风试验[IST-3]）：一项随机对照试验
3. The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke [J] . Nicola Logallo, Christopher E Kvistad, Aliona Nacu, BMC Neurology . 2014 ,第1期

机译：挪威tenecteplase中风试验（NOR-TEST）：tenecteplase与alteplase在急性缺血性中风中的随机对照试验
4. Case study of patients participating in a randomised controlled trial of upper-limb robotic rehabilitation in acute stroke services [C] . Jackson A.E., Levesley M.C., Makower S.G., Proceedings of the IEEE/RAS-EMBS International Conference on Rehabilitation Robotics . 2015

机译：参加急性卒中服务中上肢机器人康复随机对照试验的患者的案例研究
5. Effects of Imperatae Rhizoma and Lycium Barbarum Decoction in Treating Persistent Asymptomatic Isolated Hematuria in Children: An Exploratory Randomized, Open-label, Controlled Trial [D] . Yu, Yuanyuan. 2016

机译：白茅根和枸杞子汤治疗儿童持续性无症状孤立性血尿的效果：探索性随机，开放标签，对照试验
6. Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial IST-3): 18-month follow-up of a randomised controlled trial [O] . -1

机译：急性缺血性卒中后6小时内阿替普酶溶栓对长期预后的影响（第三次国际卒中试验IST-3）：一项随机对照试验的18个月随访
7. Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial [O] . Sandercock, Peter, Wardlaw, Joanna, Dennis, Martin, 2013

机译：急性缺血性卒中6小时内阿替普酶溶栓对长期预后的影响（第三次国际卒中试验[IsT-3]）：随机对照试验随访18个月

Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial

摘要

著录项

相似文献

相关主题

期刊订阅